Passage Bio, Inc. (PASG) earnings
PASG earnings moved a median of -4.99% by the close. Quarterly and annual PASG reports and results, each read against the price at its own news timestamp. Back to the PASG overview →
18 measured PASG earnings events.
Where these PASG earnings landedvs 15 measured PASG earnings reactions
| Middle 50% of PASG earnings reactions | -9.25% to +4.40% |
|---|---|
| Median reaction (to close) | -4.99% |
| Measured reactions | 15 |
Point-in-time · zero look-ahead
Half of the 15 PASG earnings events with a measured close landed between -9.25% and +4.40%; 27% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Passage BIO, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +8.93% | |
| Form 10-Q Passage BIO, Inc. For: Jun 30 | SEC filing · Form 10-Q | -0.69% | — | |
| Form 10-Q Passage BIO, Inc. For: Mar 31 | SEC filing · Form 10-Q | +4.84% | +15.90% | |
| Form 10-K Passage BIO, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | -4.99% | |
| Form 10-Q Passage BIO, Inc. For: Sep 30 | SEC filing · Form 10-Q | -0.16% | +20.13% | |
| Passage Bio Reports Third Quarter 2025 Financial Results and Provides Recent Business Highlights | Press release | -0.16% | +20.13% | |
| Form 10-Q Passage BIO, Inc. For: Jun 30 | SEC filing · Form 10-Q | -2.65% | — | |
| Passage Bio Reports Second Quarter 2025 Financial Results and Provides Recent Business Highlights | Press release | -2.65% | — | |
| Form 10-Q Passage BIO, Inc. For: Mar 31 | SEC filing · Form 10-Q | -2.54% | -8.64% | |
| Passage Bio Reports First Quarter 2025 Financial Results and Provides Recent Business Highlights | Press release | -2.54% | -8.64% | |
| Form 10-K Passage BIO, Inc. For: Dec 31 | SEC filing · Form 10-K | +1.08% | -9.49% | |
| Form 10-Q Passage BIO, Inc. For: Sep 30 | SEC filing · Form 10-Q | -1.49% | -13.13% | |
| Passage Bio Reports Third Quarter 2024 Financial Results and Provides Recent Business Highlights | Press release | -1.49% | -13.13% | |
| Form 10-Q Passage BIO, Inc. For: Jun 30 | SEC filing · Form 10-Q | +8.81% | -0.14% | |
| Passage Bio Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights | Press release | +8.81% | -0.14% | |
| Form 10-Q Passage BIO, Inc. For: Mar 31 | SEC filing · Form 10-Q | -0.60% | -9.25% | |
| Passage Bio Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights | Press release | -0.60% | -9.25% | |
| Form 10-K Passage BIO, Inc. For: Dec 31 | SEC filing · Form 10-K | -1.16% | -0.58% |
Keep exploring
More PASG: analyst actions → · SEC filings → · PASG overview →